You can easily rotate a baseball in your hand by twisting your fingers. But you need inventive scientists with access to world-class scientific facilities to rotate an object that is only two billionths of a meter wide. That is a million times smaller than a raindrop. | |
Scientists at the U.S. Department of Energy’s (DOE) Argonne National Laboratory report they can precisely rotate a single molecule that small on demand (Nature Communications, “Atomically precise control of rotational dynamics in charged rare-earth complexes on a metal surface”). The key ingredient is a single atom of europium, a rare earth element. It rests at the center of a complex of different atoms and gives the molecule many potential applications. |
“We are able to rotate this europium complex by 60 or 120 degrees to the right or left,” said Saw Wai Hla, physicist at the Center for Nanoscale Materials (CNM), a DOE Office of Science user facility at Argonne, and a physics professor at Ohio University. “The ability to control the motion of a rare earth complex such as this could impact a wide spectrum of technologies.” That includes next generation microelectronics, quantum technologies, catalysis to speed up reactions, conversion of light into electricity and more. | |
The term “rare earth” is deceptive. The rare earth elements are not exactly rare but are critical materials used in many electronic devices, such as cellular phones, computer hard drives, solar panels and flat screen monitors. The capability to rotate this europium molecule on demand could expand their applications into next generation microelectronics that run with relatively low power, quantum computers and more. | |
Rare earths readily combine with other elements in the Earth’s crust. It is thus difficult and costly to produce pure rare earths for devices. It is also expensive to harvest them from rare-earth containing waste. The team’s europium complex would reduce the amount of rare earth needed for a particular device and would be much less expensive to manufacture in mass quantities. |
Key components in the complex are a single europium atom with positive charge and two small molecules with negative charge. The europium atom sits at the center of the complex, while one of the small molecules is on the side and the other at the bottom. | |
Because opposites attract, these negative and positive charges keep these components together without the need for a chemical bond. And the small molecule at the bottom anchors the complex to a sheet of gold. This sheet acts like a table to hold the whole complex in one place, just as you need a flat solid surface to spin a bottle. | |
“Normally, if you attach a complex like ours with positive and negative charges to a metal sheet, the charges dissipate,” Hla said. “So, we were thrilled when that did not happen here. Our calculations indicated that the atoms in the complex surrounding the europium atom act as an insulator that prevents the charges from dissipating to the gold sheet.” | |
The two negatively charged molecules in the complex work together to act as a control unit. To spark the rotation, the team applied electrical energy to a specific point on the complex through the tip of an instrument called a scanning tunneling microscope. This probe not only controls the rotation but also can visualize the complex for study. | |
At a temperature of 100 Kelvin (minus 208 Fahrenheit), the team’s complex rotates constantly. That rotation stops when they decrease the temperature to an ultracold 5 K. Applying the electric energy starts the desired rotation of 60 or 120 degrees, clockwise or counterclockwise depending on where the electric field is directed. |
“Developing, fabricating and testing this nanoscale complex would not have been possible without the one-of-a-kind instruments in CNM,” Hla said. | |
What’s more, a beamline (XTIP) in the Advanced Photon Source, a DOE Office of Science user facility at Argonne, provided the high-brilliance X-ray beam needed to establish that the single europium atom had a positive charge. “XTIP is the world’s first beamline dedicated to the technique of synchrotron X-ray scanning tunneling microscopy,” said Volker Rose, an Argonne physicist with a joint appointment at Ohio University. | |
“With the XTIP beamline we were able to characterize the elemental and chemical states of the europium-containing molecule,” said assistant physicist Nozomi Shirato. These data established that the single europium atom in the molecule has a positive charge of plus three and does not lose that charge when absorbed on the gold surface. This retention of the charge state is key to the ability to rotate the molecule. | |
“Our primary mission is to understand at the level of atoms the properties of rare earths, which are critical materials to U.S. industry,” added Hla. “This particular project could beneficially impact many different technologies that exist now or could be developed.” |
News
Antibody engineering drives innovation in drug development
Monoclonal antibodies (mAbs) are used to prevent, detect, and treat a broad spectrum of non-communicable and communicable diseases. Over the past few years, the market for mAbs has grown exponentially with an expected compound [...]
Breakthrough Study Reveals How Bladder Cancer Starts and Spreads
Researchers found that DNA mutations from antiviral enzymes and chemotherapy fuel early bladder cancer, while abnormal circular DNA in tumor cells drives resistance to therapy. These discoveries open new therapeutic avenues. A groundbreaking study led by [...]
AI and Quantum Mechanics Accelerate Drug Discovery
A recent article published in the Journal of Chemical Information and Modeling researchers at Southern Methodist University (SMU) have developed SmartCADD, an open-source virtual tool designed to speed [...]
Targeting ‘undruggable’ diseases: Researchers reveal new levels of detail in targeted protein degradation
Researchers at the University of Dundee have revealed in the greatest detail yet the workings of molecules called protein degraders which can be deployed to combat what have previously been regarded as "undruggable" diseases, [...]
Revolutionizing Virology: AI Discovers Over 160,000 New RNA Viruses
Largest discovery of new virus species sheds light on the hidden virosphere. Artificial intelligence (AI) has been used to reveal details of a diverse and fundamental branch of life living right under our feet and in every [...]
Cardiac Crisis: COVID-19 Doubles Risk of Heart Attacks, Strokes, and Death
Research indicates that COVID-19 survivors face doubled risks of severe cardiac events for years after recovery, especially if hospitalized. People with A, B, or AB blood types are particularly vulnerable, highlighting the need for personalized approaches [...]
AI steps into science limelight with Nobel wins
For long periods of its history, artificial intelligence has lurked in the hinterland of science, often unloved and unfunded—but two Nobel prizes in one week suggest its time in the sunshine has finally arrived. [...]
MIT Scientists Shed New Light on the Critical Brain Connections That Define Consciousness
A new study provides further evidence that consciousness depends on communication between the brain’s sensory and cognitive regions in the cortex. Our brains are constantly making predictions about our surroundings, enabling us to focus [...]
Common Chemicals Found in Shampoo and Plastic Could Be Quietly Disrupting Your Heart’s Rhythm
UC study of Fernald data links environmental phenols to heart toxicities Environmental phenols are present in numerous everyday consumer products, serving as preservatives in packaged foods, parabens in shampoos, and bisphenol A (BPA) in [...]
Revolutionary Brain Tech Offers New Hope for Stroke and Injury Recovery
University of Pittsburgh researchers report that deep brain stimulation (DBS) can effectively enhance motor functions in individuals with arm and hand paralysis due to brain injuries, with promising results from early human and monkey [...]
NIH Scientists Discover Gene Responsible for Rare Eye Disease
Findings supported by the NIH pave the way for the development of genetic testing, clinical trials, and therapies. Researchers at the National Institutes of Health (NIH) and their collaborators have discovered a gene linked to certain [...]
Alzheimer’s Breakthrough: Synthetic THC Pill Proves Effective in Clinical Trial
Patients tolerated synthetic THC (dronabinol) well, without the adverse effects commonly associated with existing Alzheimer’s agitation medications. A study conducted by researchers from Johns Hopkins University School of Medicine and Tufts University School of Medicine found that a pill form [...]
The Future of Rare Disease Treatment with Precision Medicine
Understanding rare diseases Rare diseases affect less than 5 people out of 10,000. However, this still amounts to about 7% of the world’s population, with over 10,000 such conditions. Almost all are genetic in [...]
Doctors issue warning for upcoming ‘tripledemic
The term ‘tripledemic’ has hit headlines this week as the NHS begins its Covid and fluvaccine roll-out for vulnerable adults. As the cold weather sets in, many of us have experienced a decline in health, and this may [...]
The FDA approved a gel that can stop bleeding from wounds in seconds
Aug 15 (Reuters) - The U.S. Food and Drug Administration has cleared Cresilon's gel to quickly control bleeding, the privately held company said on Thursday, potentially giving emergency medical technicians and combat medics a [...]
High levels of microplastics found in prostate tumors, possibly linked to take-out food
The presence of microplastics in prostate tumors points to potential health risks, and researchers are calling for urgent studies to explore how take-out food may be driving this exposure. In a recent study published [...]